Cannabinoid Receptors in Diabetic Kidney Disease (Q49331469)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 February 2018

edit

Language	Label	Description	Also known as
English	Cannabinoid Receptors in Diabetic Kidney Disease	scientific article published on 5 February 2018

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

title

Cannabinoid Receptors in Diabetic Kidney Disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

main subject

CNR2

0 references

cannabinoids

0 references

cannabinoid receptor

0 references

author name string

F Barutta

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

R Mastrocola

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

S Bellini

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

G Bruno

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

Gabriella Gruden

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

publication date

5 February 2018

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

published in

Current diabetes report

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

page(s)

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

cites work

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological actions of cannabinoids.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoids: synthesis and degradation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signaling at the slit: podocytes chat by synaptic transmission

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the MCP-1/CCR2 System in diabetic kidney disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of diabetic complications.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid receptor 2 expression in human proximal tubule cells is regulated by albumin independent of ERK1/2 signaling

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic kidney disease: a report from an ADA Consensus Conference

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid receptor 1 is a major mediator of renal fibrosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoid signaling at the periphery: 50 years after THC.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the endocannabinoid system in diabetes and diabetic complications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Innate immunity in diabetes and diabetic nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29399721

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11892-018-0975-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

Dimensions Publication ID

1100822398

0 references

PubMed publication ID

29399721

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29399721

retrieved

20 February 2018

reference URL

http://europepmc.org/abstract/MED/29399721

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49331469&oldid=2225497221"